NCT01761877View on ClinicalTrials.gov

NSAID Effects on Clinical and Imaging Breast Biomarkers

PHASE2CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 7, 2019

Study Completion Date

March 11, 2019

Conditions
InflammationCancerPainHypertension
Interventions
DRUG

Sulindac

Trial Locations (2)

11794

Stony Brook University Cancer Center, Stony Brook

85724

University of Arizona Cancer Center, Tucson

All Listed Sponsors
lead

Stony Brook University

OTHER

NCT01761877 - NSAID Effects on Clinical and Imaging Breast Biomarkers | Biotech Hunter | Biotech Hunter